| The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution Cell 181 (2), 236-249, 2020 | 378 | 2020 |
| Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma T Risom, DR Glass, I Averbukh, CC Liu, A Baranski, A Kagel, ... Cell 185 (2), 299-310. e18, 2022 | 193 | 2022 |
| Prognostic DNA methylation markers for prostate cancer SH Strand, TF Orntoft, KD Sorensen International journal of molecular sciences 15 (9), 16544-16576, 2014 | 116 | 2014 |
| Hypermethylation of the GABRE∼ miR-452∼ miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy H Kristensen, C Haldrup, S Strand, K Mundbjerg, MM Mortensen, ... Clinical Cancer Research 20 (8), 2169-2181, 2014 | 103 | 2014 |
| Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer KD Sørensen, MO Abildgaard, C Haldrup, BP Ulhøi, H Kristensen, ... British journal of cancer 108 (2), 420-428, 2013 | 65 | 2013 |
| Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies C Haldrup, AL Pedersen, N Øgaard, SH Strand, S Høyer, M Borre, ... Molecular Oncology 12 (4), 545-560, 2018 | 58 | 2018 |
| Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer TM Storebjerg, SH Strand, S Høyer, AS Lynnerup, M Borre, TF Ørntoft, ... Clinical epigenetics 10, 1-16, 2018 | 48 | 2018 |
| HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer H Ross-Adams, S Ball, K Lawrenson, S Halim, R Russell, C Wells, ... Oncotarget 7 (46), 74734, 2016 | 44 | 2016 |
| Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients M Møller, SH Strand, K Mundbjerg, G Liang, I Gill, C Haldrup, M Borre, ... Scientific reports 7 (1), 40636, 2017 | 42 | 2017 |
| MITI minimum information guidelines for highly multiplexed tissue images D Schapiro, C Yapp, A Sokolov, SM Reynolds, YA Chen, D Sudar, Y Xie, ... Nature methods 19 (3), 262-267, 2022 | 41 | 2022 |
| Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients L Schmidt, J Fredsøe, H Kristensen, SH Strand, A Rasmussen, S Høyer, ... Annals of oncology 29 (9), 2003-2009, 2018 | 36 | 2018 |
| High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer SH Strand, S Hoyer, AS Lynnerup, C Haldrup, TM Storebjerg, M Borre, ... Clinical epigenetics 7, 1-12, 2015 | 36 | 2015 |
| Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer MT Bjerre, SH Strand, M Nørgaard, H Kristensen, AKI Rasmussen, ... International journal of molecular sciences 20 (5), 1173, 2019 | 35 | 2019 |
| FRMD6 has tumor suppressor functions in prostate cancer J Haldrup, SH Strand, C Cieza-Borrella, ME Jakobsson, M Riedel, ... Oncogene 40 (4), 763-776, 2021 | 26 | 2021 |
| RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy SH Strand, M Switnicki, M Moller, C Haldrup, TM Storebjerg, J Hedegaard, ... Oncotarget 8 (4), 5774, 2017 | 25 | 2017 |
| Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ... Cancer cell 40 (12), 1521-1536. e7, 2022 | 24 | 2022 |
| Epigenetic analysis of circulating tumor DNA in localized and metastatic prostate cancer: evaluation of clinical biomarker potential MT Bjerre, M Nørgaard, OH Larsen, SØ Jensen, SH Strand, P Østergren, ... Cells 9 (6), 1362, 2020 | 22 | 2020 |
| Elevated miR-615-3p expression predicts adverse clinical outcome and promotes proliferation and migration of prostate cancer cells EB Laursen, J Fredsøe, L Schmidt, SH Strand, H Kristensen, ... The American Journal of Pathology 189 (12), 2377-2388, 2019 | 22 | 2019 |
| A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy SH Strand, E Bavafaye‐Haghighi, H Kristensen, AK Rasmussen, S Hoyer, ... International Journal of Cancer 145 (12), 3445-3452, 2019 | 16 | 2019 |
| Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases L Schmidt, M Møller, C Haldrup, SH Strand, S Vang, J Hedegaard, ... British journal of cancer 119 (12), 1527-1537, 2018 | 14 | 2018 |
Karina Dalsgaard SorensenAarhus University, DenmarkVerified email at clin.au.dk
